Showing 9991-10000 of 20894 results for "".
Ethical Concerns in a Potential Influenza Pandemic
https://reachmd.com/programs/clinicians-roundtable/ethical-concerns-in-a-potential-influenza-pandemic/78/Dr. Ruth Faden discusses the ethical issues physicians and policy makers may face in the advent of a global influenza pandemic. Global health care responsibilities such as ensuring equiity of treatment on a grand scale, are addressed. Added, questions on our level of preparedness for such an event aInsurance Company Impact on Doctors
https://reachmd.com/programs/clinicians-roundtable/insurance-company-impact-on-doctors/41/Dr. DeAngeles discusses the changes insurance companies have had on treatment options, testing and reimbursement for the medical professional.Insurance Company Impact on the Doctor
https://reachmd.com/programs/clinicians-roundtable/insurance-company-impact-on-the-doctor/40/Dr. DeAngeles discusses the changes insurance companies have had on treatment options, testing and reimbursement for the medical professional.Influence of Advertising on Children
https://reachmd.com/programs/clinicians-roundtable/influence-of-advertising-on-children/37/Dr. Strasburger identifies advertising trends in the media and the effect these trends ultimately have on children's health.Predictors of Emergency Department Use by Persons with Inflammatory Bowel Diseases: A Population-Based Study
https://reachmd.com/programs/Audioabstracts/predictors-emergency-department-use-persons-with-inflammatory-bowel-diseases-population-based-study/8566/Identified predictors of ED attendance and post-ED hospitalization could guide the optimization of outpatient IBD care.Why Participating in Improvement Activities Matters
https://reachmd.com/programs/perspectives-ama/why-participating-improvement-activities-matters/8366/An overview of the Improvement Activities, category, including how the activities may be reported and scored by CMS.Innovations in IgAN Care: Examining the Evolving Treatment Landscape
https://reachmd.com/programs/frontlines-iga-nephropathy/innovations-in-igan-care-examining-the-evolving-treatment-landscape/26941/Tune in to hear about the latest treatment advancements in IgA nephropathy.ECG Markers as Predictors of Adverse Outcomes in COPD: Insights from the IMPACT Trial
https://reachmd.com/programs/frontlines-copd/ecg-markers-as-predictors-of-adverse-outcomes-in-copd-insights-from-the-impact-trial/35536/A post hoc analysis of the IMPACT trial evaluated two electrocardiographic biomarkers—CIIS and P pulmonale—as predictors of mortality, hospitalizations, and exacerbations in patients with chronic obstructive pulmonary disease (COPD). According to the findings, both biomarkers were linked with increaOvercoming Clinical Inertia to Individualize Myelofibrosis Treatment
https://reachmd.com/programs/project-oncology/individualizing-myelofibrosis-treatment/59183/As the treatment landscape for myelofibrosis continues to evolve, timely and individualized decision-making is essential to improving patient outcomes. That’s why Dr. Prithviraj Bose joins Dr. Alexandria May to explore how clinicians can overcome clinical inertia by initiating appropriate therapy eaUnderstanding IL-36 Signaling in GPP and Related Neutrophilic Dermatoses
https://reachmd.com/programs/dermconsult/il-36-signaling-gpp-neutrophilic-dermatoses/56721/What role does IL-36 signaling play in generalized pustular psoriasis (GPP) and why is it an emerging focus in neutrophilic inflammatory disease? Join Dr. Charles Turck and Dr. David Cotter, a dermatologist at Las Vegas Dermatology, as they explore the genetic and acquired mechanisms underlying IL-3